Chronic inducible urticaria (CIU) represents a challenging dermatological condition characterized by persistent hives triggered by various stimuli. The global market for CIU treatments is estimated to experience rapid increase over the foreseeable few years, driven by influences such as rising prevalence of CIU, improved diagnostic capabilities, an